HCA Healthcare (NYSE:HCA) Price Target Lowered to $355.00 at Morgan Stanley

HCA Healthcare (NYSE:HCA) had its target price reduced by Morgan Stanley from $406.00 to $355.00 in a report published on Tuesday morning,Benzinga reports. They currently have an equal weight rating on the stock.

A number of other brokerages have also recently issued reports on HCA. Oppenheimer increased their target price on shares of HCA Healthcare from $390.00 to $400.00 and gave the company an “outperform” rating in a report on Monday, October 28th. Raymond James downgraded HCA Healthcare from an “outperform” rating to a “market perform” rating in a research report on Friday, November 22nd. KeyCorp cut their price target on HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating for the company in a research note on Monday, October 28th. Barclays dropped their target price on shares of HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating for the company in a report on Friday, November 8th. Finally, Truist Financial increased their price target on shares of HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a research report on Monday, August 19th. One analyst has rated the stock with a sell rating, four have assigned a hold rating, twelve have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $385.63.

HCA Healthcare Price Performance

Shares of NYSE HCA opened at $297.52 on Tuesday. The company’s fifty day moving average is $348.93 and its two-hundred day moving average is $357.51. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12. The firm has a market capitalization of $75.36 billion, a P/E ratio of 13.36, a PEG ratio of 1.21 and a beta of 1.63. HCA Healthcare has a one year low of $263.22 and a one year high of $417.14.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be issued a dividend of $0.66 per share. The ex-dividend date of this dividend is Friday, December 13th. This represents a $2.64 annualized dividend and a dividend yield of 0.89%. HCA Healthcare’s payout ratio is currently 11.85%.

Insider Buying and Selling

In other news, SVP Phillip G. Billington sold 3,897 shares of the business’s stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the completion of the sale, the senior vice president now owns 52,702 shares in the company, valued at approximately $18,445,700. The trade was a 6.89 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Erol R. Akdamar sold 2,900 shares of HCA Healthcare stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the transaction, the insider now directly owns 6,843 shares in the company, valued at approximately $2,415,579. This trade represents a 29.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On HCA Healthcare

Several hedge funds and other institutional investors have recently made changes to their positions in HCA. Fifth Third Bancorp grew its stake in shares of HCA Healthcare by 3.6% in the second quarter. Fifth Third Bancorp now owns 9,866 shares of the company’s stock valued at $3,170,000 after buying an additional 347 shares in the last quarter. Atria Wealth Solutions Inc. lifted its position in shares of HCA Healthcare by 25.8% during the second quarter. Atria Wealth Solutions Inc. now owns 3,280 shares of the company’s stock worth $1,054,000 after purchasing an additional 672 shares in the last quarter. &PARTNERS increased its stake in HCA Healthcare by 1.6% during the 2nd quarter. &PARTNERS now owns 10,762 shares of the company’s stock worth $3,458,000 after buying an additional 168 shares during the period. Unique Wealth Strategies LLC purchased a new position in HCA Healthcare in the 2nd quarter valued at about $28,000. Finally, My Legacy Advisors LLC purchased a new stake in shares of HCA Healthcare during the second quarter worth about $1,802,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.